The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CRMD FINANCIAL STATEMENTS

CorMedix Inc — balance sheet, income statement and cash flow trends

CRMDCorMedix Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0200 M400 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue462.2 M $Gross Profit382.6 M $ · 83%Operating Income217 M $ · 47%Pre-tax Income203.4 M $ · 44%Net Income to Owners187.2 M $ · 40%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue462.2 M $+280.5%
Gross Profit382.6 M $+229.4%
Operating Income217 M $+340.1%
EBITDA249.6 M $+377.6%
Net Income to Owners187.2 M $+265.9%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets904.1 M
  • Equity460.8 M $51%
  • Current Liabilities187.4 M $21%
  • Long-term Liabilities255.8 M $28%

Key Figures

YoY change
Total Assets904.1 M $+257.9%
Total Liabilities443.2 M $+1,286.4%
Total Equity460.8 M $+108.9%
Cash & ST Investments256.7 M $+34.6%
Total Debt145.2 M $+33,249.0%
Net Debt-111.5 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0100 M200 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0100 M200 M253.9 M $Operating-285.6 M $Investing129.9 M $Financing98.3 M $Net Change

Key Figures

YoY change
Operating Cash Flow253.9 M $+733.6%
Capital Expenditures3.7 M $+6,752.8%
Free Cash Flow251.7 M $+727.7%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CRMD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.